Neo-Oxy 100/100 MR description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Neo-Oxy 100/100 MR

PennField Oil Company




FULL PRESCRIBING INFORMATION

Enter section text here

Active ingredient

ACTIVE DRUG INGREDIENTS:

Oxytetracycline Hydrochloride  100 g/lb.

Neomycin Sulfate  100 g/lb.

MIXING AND USE DIRECTIONS

Mix Neo-Oxy 100/100 MR with nonmedicated milk replacer to provide the following concentrations:

Uses

CALVES (milk replacer) - For calves (up to 250 lb) for increased rate of weight gain and improved feed efficiency.

Oxytetracycline and Neomycin Amount:  0.05-0.1 mg/lb of body weight daily.  Feed continuously; in milk replacers or starter feed.

Lb of Neo-Oxy 100/100 MR per ton of Type C Medicated Feed (1):  0.1-0.2 (2)


RESIDUE WARNING:  Zero day withdrawal.  Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues.

Uses

For calves (up to 250 lb) for treatment of bacterial enteritis caused by E. coli susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin.

Oxytetracycline and Neomycin Amount:  10 mg/lb of body weight daily.  Feed continuously for 7-14 days in milk replaces or starter feed.  If symptoms persist after using 2 or 3 days, consult a veterinarian.  Treatment should continue 24 to 48 hours beyond remission of disease symptoms.

Lb of Neo-Oxy 100/100 MR per ton of Type C Medicated Feed (1): 20 (2)

RESIDUE WARNING:  A withdrawal period has not been established for use in preruminating calves.  Do not use in calves to be processed for veal.  A milk discard time has not been established for use in lactating dairy cattle.  Do not use in female dairy cattle 20 months or older.  Withdraw 5 days before slaughter.  Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues.

Uses

CALVES, BEEF CATTLE, AND NONLACTATING DAIRY CATTLE

For treatment of bacterial enteritis caused by E. coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocide susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin.

Oxytetracycline and Neomycin Amount:  10 mg/lb of body weight daily.  Feed continuously for 7-14days in feed or milk replaces.  If symptoms persist after using 2 or 3 days, consult a veterinarian.  Treatment should continue 24 to 48 hours beyond remission of disease symptoms.

Lb of Neo-Oxy 100/100 MR per ton of Type C Medicated Feed (1):  20 (2)

RESIDUE WARNING:  A withdrawal period has not been established for use in preruminating calves.  Do not use in calves to be processed for veal.  A milk discard time has not been established for use in lactating dairy cattle.  Do not use in female dairy cattle 20 months or older.  Withdraw 5 days before slaughter.  Use of more than one product containing neomycin or failure to follow withdrawal times may result in illegal drug residues.

Uses

(1)  Mixing directions are for example only and are based on mixing 1 lb of dry milk with 1 gallon of water.

(2)  If calf weighs 100 lb, consuming 1 gallon of milk replaced per day.


FOR USE IN DRY FEEDS ONLY.  NOT FOR USE IN LIQUID FEED SUPPLEMENTS.

 Store at 25 Degrees C (77 Degrees F) with excursions permitted to 37 Degrees C (98.6 Degrees F)

Restricted Drug (California) - Use Only as Directed

Not For Human Use

Neo-Oxy 100/100 MREnter section text here

Neo-Oxy 100/100 MR

Oxytetracycline Hydrochloride POWDER

Product Information

Product Type Otc type a medicated article animal drug label Item Code (Source) NDC:48164-0030
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
Neomycin Sulfate NEOMYCIN 220.2 g
Oxytetracycline Hydrochloride OXYTETRACYCLINE ANHYDROUS 220.5 g

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:48164-0030-0 220.5 in 1 DRUM

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA138939 2009-12-18


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.